Clinical Trial Update: To Evaluate Effectiveness and Safety of Containing Raltegravir in Naive HIV NON B or B Infected Patients

View source ↗

Summary

A clinical trial update evaluating the effectiveness and safety of raltegravir in treatment-naive patients infected with HIV-1, including non-B subtypes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Isentress (Raltegravir)

Snippet

Sponsor: Centre Hospitalier Intercommunal Robert Ballanger | Conditions: Evaluated, Non B Subtype | Status: UNKNOWN